SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-326323
Filing Date
2018-11-14
Accepted
2018-11-14 09:17:46
Documents
31
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d580563d10q.htm 10-Q 203329
2 EX-31.1 d580563dex311.htm EX-31.1 6755
3 EX-31.2 d580563dex312.htm EX-31.2 6732
4 EX-32.1 d580563dex321.htm EX-32.1 5337
  Complete submission text file 0001193125-18-326323.txt   1361848

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20180930.xml EX-101.INS 204282
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20180930.xsd EX-101.SCH 19426
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20180930_cal.xml EX-101.CAL 21592
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20180930_def.xml EX-101.DEF 33139
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20180930_lab.xml EX-101.LAB 167762
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20180930_pre.xml EX-101.PRE 105161
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 181180681
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1